Indeed, in human tumours with altered arachidonic acid catabolism or exaggerated alarmin production (e.g., IL-3345), the ILC2-IL-13-M-MDSC network might represent a novel, early acting innate pathway of immune regulation. This evidence concerns the gene IL13 and neoplasm.